INSIGHTS: Creating Buzz Around Your Startup: How to raise visibility and build momentum - Iraj Ali (former CEO Achilles Therapeutics)
Oct
8

INSIGHTS: Creating Buzz Around Your Startup: How to raise visibility and build momentum - Iraj Ali (former CEO Achilles Therapeutics)

A well-orchestrated narrative can accelerate your venture. When it's misaligned either too cautious or too promotional, it limits optionality rather than creating any. Iraj Ali has worked at that edge. He raised significant capital, led a UK-based company through a U.S. IPO during a global crisis, and maintained credibility through market shifts and programmatic changes. His perspective will offer you a unique view into how narrative clarity, when actively managed, reinforces strategy not just externally, but inside the organisation as well.

View Event →
INSIGHTS: Executive Presence - The Key to Investor Confidence in You - Joel Garfinkle (Author and Executive Coach)
Oct
22

INSIGHTS: Executive Presence - The Key to Investor Confidence in You - Joel Garfinkle (Author and Executive Coach)

In early-stage biotech, investors aren’t just betting on the science, they’re betting on you. Your groundbreaking science got you this far, but in investor meetings, how you show up matters as much as what you’ve discovered. Your executive presence is what transforms brilliant science into investor confidence. Joel Garfinkle is based in the US, on the West Coast. He is the bestselling author of Executive Presence: Step Into Your Power, Convey Confidence, & Lead With Conviction and has coached over 2,500 leaders worldwide, including helping pharma and biotech executives become confident, commanding leaders. He is a Master Certified Coach and recognized as one of the top 15 executive coaches in the world.

View Event →

INSIGHTS: The Importance of Company Culture in Early Start-Ups - Kevin Pojasek (Founder and CEO of Enara Bio)
Sept
10

INSIGHTS: The Importance of Company Culture in Early Start-Ups - Kevin Pojasek (Founder and CEO of Enara Bio)

Kevin brings a broad vantage point to the culture conversation: as a repeat CEO and a Venture Partner/EIR inside venture capital firms on both sides of the Atlantic, he has seen culture done well and done less well. He has brought his insights into authentic and people-focused leadership to Enara to help build the company’s culture from its earliest days as a seed-funded company through to where it stands today. Enara’s internal work was recently validated through the iEVP survey that we ran withing the LifeScience ORG community, developed by Harvard’s Amy Edmondson and INSEAD’s Mark Mortensen, revealing a rare alignment between leadership intention and employee perception. Kevin draws on frameworks from Reinventing Organizations by Frederic Laloux, but applies them within the high-consequence environment of early-stage life sciences.

View Event →
INSIGHTS/ The CEO: Pedro Gómez  (Orbem ) - Platform Thinking, Practical Strategy
Jul
8

INSIGHTS/ The CEO: Pedro Gómez  (Orbem ) - Platform Thinking, Practical Strategy

Pedro Gómez - CEO and co-founder of Orbem

Orbem is a Munich-based techbio company unlocking new applications for AI-powered imaging. Founded as a spin-out from the Technical University of Munich, Orbem has raised over >€50 million and built strategic partnerships across sectors including agriculture, health, and logistics. Pedro holds a PhD in Biomedical Imaging and Informatics and has led the company from academic research through product development, fundraising, and commercial deployment.

View Event →
INSIGHTS/ The Expert- Emma Tinsley (CEO Weatherden): Your Asset is not your Strategy: Build the Path to Value at Speed.
Jun
11

INSIGHTS/ The Expert- Emma Tinsley (CEO Weatherden): Your Asset is not your Strategy: Build the Path to Value at Speed.

Emma Tinsley - CEO and co-founder of Weatherden

Prior to co-founding Weatherden, Emma was part of SV Health Investors, where she specialised in venture capital company creation, forming five biotech companies across immunology and oncology. Earlier in her career, she worked within the Life Sciences team at KPMG.

View Event →
INSIGHTS/ The Experts (Cooley LLP and M Ventures): Navigating Term Sheets Through the Founder and Investor Lens
May
28

INSIGHTS/ The Experts (Cooley LLP and M Ventures): Navigating Term Sheets Through the Founder and Investor Lens

Tom Goodman and Ellen Dewhurst - Cooley LLP

Nadiya Ishnazarova and Christian Uhrich - M Ventures

We asked an investor and a law firm to join us for this conversation, as these two perspectives will illuminate the nuances founders must understand - across legal protections, economic rights, and governance control.

View Event →
WORKSHOP: Florian Burgdorf (The Boston Consulting Group) - Negotiation Best Practices and Exercises (Part2)
May
7

WORKSHOP: Florian Burgdorf (The Boston Consulting Group) - Negotiation Best Practices and Exercises (Part2)

Florian Burgdorf - Global Head of Procurement Academy 4.0 and Negotiation Trainings at Boston Consulting Group

Florian holds a PhD in Electrical Engineering and is a leading member of BCG's Operations and Industrial Goods practice areas, with a focus on procurement and R&D transformations, both digital and conventional.

View Event →
INSIGHTS/ The CEO: Barnaby Balmforth (BioFidelity) - Competing on the international stage
Dec
4

INSIGHTS/ The CEO: Barnaby Balmforth (BioFidelity) - Competing on the international stage

Barnaby Balmforth - CEO and Co-Founder of BioFidelity

Barnaby’s strategic approach to team building on both sides of the Atlantic - emphasizing the recruitment of top talent, fostering an agile and innovative culture, and aligning the team with BioFidelity’s global mission - has been critical to the company’s rapid growth and international success.

View Event →
Female Founder Exchange - Marina Udier (CEO of Nouscom)
Oct
23

Female Founder Exchange - Marina Udier (CEO of Nouscom)

Marina Udier - CEO at Nouscom

In our new Female Founder Exchange Series, we will be asking seasoned life science CEOs to name the three biggest challenges (personal and/or professional) that they have encountered or are encountering by virtue of being a female leader and share what they did or are doing to overcome them.

View Event →
INSIGHTS / The Experts: François Candelon & Leonid Zhukov (BCG Henderson Institute) - How can GenAI expand your workforce?
Oct
16

INSIGHTS / The Experts: François Candelon & Leonid Zhukov (BCG Henderson Institute) - How can GenAI expand your workforce?

François Candelon & Leonid Zhukov - BCG Henderson Institute

François Candelon is currently a Partner at Seven2, a French private equity firm. Previously, he served as the Global Director of the BCG Henderson Institute (2019-2024).

Leonid Zhukovis the Director of the BCG Global AI Institute, where he plays a pivotal role in exploring how artificial intelligence, particularly generative AI (GenAI), can transform industries.

View Event →